ValueHealth announces high-performance surgical joint venture with Pennsylvania-based Doylestown Health System

ValueHealth, LLC, a nationally recognized, tech-enabled surgical platform company, is pleased to announce a new surgical joint venture with Doylestown Health, ranked among the best hospitals in the United States, the commonwealth of Pennsylvania, and the Greater Philadelphia region. This strategic partnership will make it possible for Doylestown Health to…

Read More ValueHealth announces high-performance surgical joint venture with Pennsylvania-based Doylestown Health System

Agari gives CISOs the upper hand in fight against chronic phishing and BEC attacks

Agari, the market share leader in phishing defense solutions for the enterprise, today unveiled Agari Active Defense with a new service that delivers actionable threat intelligence driven through active engagement with Business Email Compromise (BEC) threat actors. This new offering from Agari was introduced in the opening CEO keynote today…

Read More Agari gives CISOs the upper hand in fight against chronic phishing and BEC attacks

ARCO Design/Build completes new manufacturing and test site for Archway Properties and AFGlobal in Waller, TX

ARCO Design/Build recently completed construction of a new manufacturing and oil rig test site featuring two buildings located at 19961 GH Circle in Waller, TX for Archway Properties and AFGlobal, a subsidiary of AFG Holdings, Inc., a provider of technology, services and fully integrated manufacturing capabilities to clients worldwide. Since…

Read More ARCO Design/Build completes new manufacturing and test site for Archway Properties and AFGlobal in Waller, TX

Bayer and OrigiMed reached a partnership to develop a next generation sequencing based companion diagnostic-in vitro diagnostic product for NTRK gene fusion detection

Bayer and OrigiMed Co., Ltd. today announced a strategic collaboration for the development and commercialization of NGS-based companion diagnostics – in vitro diagnostic (CDx-IVD) in China for detection of NTRK gene fusions. This collaboration will focus on developing a CDx-IVD for larotrectinib (Vitrakvi®) for the Chinese market, the first TRK…

Read More Bayer and OrigiMed reached a partnership to develop a next generation sequencing based companion diagnostic-in vitro diagnostic product for NTRK gene fusion detection

Menkes announces Sun Life as new partner at the Waterfront Innovation Centre

Menkes Developments Ltd. is pleased to announce that BentallGreenOak, on behalf of Sun Life Assurance Company of Canada, has acquired a 50% interest in the Waterfront Innovation Centre, a 475,000-square-foot office and retail development which neighbours Sugar Beach on Toronto’s eastern waterfront. Sun Life, a longstanding partner of Menkes, is…

Read More Menkes announces Sun Life as new partner at the Waterfront Innovation Centre